Resapp Health

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Trading Performance

Basic Candlestick

Score

-0.1

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 87 4.3 0.37% 0.49% 8.1% -4.8% -55.1%
SHORT 87 6.0 0.44% 0.64% 9.8% -5.1% 75.3%

Summary

Technical Analysis

Resapp Health (RAP.AX)


Indicator:

WHITE OPENING MARUBOZU


Last Signal:

BULLISH


Trading: BUY @ $0.195
Signal Strength: WEAK
Recommendation:

Indicator MUST BE USED in additional to another technical indicator to confirmation for trading position. Indicator can be applied to the short term timeframe but is only able to give and indication of the strength of the buyers versus sellers at the market close. This Japanese candlestick indicator can provide guidance on the short term battle between sellers and buyers from the companies recent trading.


Resapp Health (ASX:RAP) has formed a White Opening Marubozu candlestick. This means, RAP has received strong buying confidence and upward price movement over the trading day with only a small upper shadow present. Given the limited timeframe in which signal has formed, further confirmation is required through volume and additional technical indicators.



This candlestick represents extreme bullishness and it is characterized with a long white body that has an upper shadow but no lower shadow.

Calculation: White Opening Marubozu Candlestick:
1) The body of the candlestick is white and long;
2) There is no lower shadow;


PROFILE: Resapp Health (RAP.AX)


Stock Exchange: ASX
Company: Resapp Health
Ticker Codes: | RAP.AX | ASX:RAP |

About Resapp Health (ASX:RAP):

ResApp Health Limited develops and commercializes the ResApp technology to provide health care solutions for respiratory disease. The company offers telehealth companies with point of care diagnostic solutions to integrate into their platforms. It provides SMARTCOUGH-C, a multi-site, double blind, and prospective clinical study to investigate ResAppDx for the diagnosis of respiratory disease in infants and children using cough sounds, as well as the diagnosis of pneumonia, croup, bronchiolitis, asthma/reactive airways disease, lower respiratory tract disease, and upper respiratory tract infection. The company was formerly known as Narhex Life Sciences Limited. ResApp Health Limited was founded in 2014 and is headquartered in Brisbane, Australia.

Top 10:

Basic Candlestick

Download
Company Close Change(%) Volume Value Signal
DCN Dacian Gold 0.55 23.6 6,024,943 1 BULLISH
BRN Brainchip Holdings 0.08 11.6 9,040,170 0 BULLISH
GTN GTN Resources 1.1 10 161,378 1 BULLISH
LNG Liquefied Natural Gas 0.29 9.6 1,664,251 0 BULLISH
NAN Nanosonics 5.36 8.7 2,348,894 0 BULLISH
SLR Silver Lake Resources 0.94 8.7 10,759,307 1 BULLISH
TZN Terramin Australia 0.08 8.7 388,211 1 BULLISH
CUV Clinuvel Pharmaceuticals 36.49 7 293,452 0 BULLISH
VTG Vita 1.25 5.9 714,854 1 BULLISH
OMH OM Holdings 0.92 5.8 56,591 0 BULLISH